The Austin Times

A Multicultural News Source

  • Facebook
  • RSS
  • nhà cái tặng tiền cược miễn phí
  • News
  • Arts & Entertainment
  • Sports
  • Health
  • Community
  • Business
  • Food & Lifestyle
  • Opinions
  • Politics
  • Calendar
  • Technology
  • Travel
  • Fashion
  • Classifieds
  • AutoZone

Experimental vaccine may reduce risk of post-stroke blood clot

7:11 am by admin Leave a Comment

An experimental vaccine reduced the risk of post-stroke blood clot risk in a study with mice, researchers report in a new study.

Researchers in Japan hope the vaccine, called S100A9, may one day replace oral blood thinners, which are used to help prevent another stroke. The findings were published Monday in the journal Hypertension.

In addition, they found that the vaccine also doesn’t increase the risk of serious bleeding or lead to an autoimmune response.

“Many stroke patients don’t take their blood thinning drugs as prescribed, which makes it more likely they will have another stroke,” Hironori Nakagami, a professor at Osaka University and co-author on the study, said in a press release. “This vaccine might one day help solve this issue since it would only need to be injected periodically.”

Among the 795,000 Americans who have a stroke each year, 25 percent will have another stroke within their lifetime, according to the National Stroke Association. Recurrent strokes have a higher rate of death and disability because portions of the brain were injured by the original stroke or may not be as resilient.

In addition to blood thinners, doctors may include an antiaggregant such as aspirin or anticoagulant such as warfarin to help prevent a secondary stroke.

For the new study, researchers found the experimental vaccine provided protection against blood clots in mice for more than two months, and it worked as well as the oral blood thinner clopidogrel in a major artery.

Researchers say the lack of an immune response means the mice’s immune system did not perceive the vaccine as an “intruder” that needed to be attacked. This would have caused a reaction to the vaccine.

The researchers hope one day to conduct human trials of the vaccine.

“We are continuing our research in hopes of being able to start clinical trials between five and ten years from now, but there are differences between mice and humans in how the vaccine will be recognized by the immune system,” he said. “We should be able to overcome such problems and believe this vaccine provides a very promising strategy in secondary prevention of stroke.”

Filed Under: Health, Other News, Photo Gallery

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

In This Issue

Philonise Floyd to Congress on police reforms: ‘Stop the pain’

Philonise Floyd told House lawmakers Wednesday that it's their … [Read More...]

U.S. consumer prices down for 3rd month in a row

The U.S. Consumer Price Index, the gauge that measures change in the costs … [Read More...]

Pointer Sisters singer Bonnie Pointer dies

Singer Bonnie Pointer died Monday, her family said. She was 69 years … [Read More...]

New Hampshire rapper’s poetry book sets world record for alliteration

A New Hampshire rapper set a record for the world's longest alliteration … [Read More...]

Most Americans now spending less amid COVID-19 crisis

More Americans are now spending less each month than at any time since the … [Read More...]

Tiger Woods says running 30 miles a week ‘destroyed’ body

Tiger Woods said running more than 30 miles a week early on in his golf … [Read More...]

News Archives

  • Facebook
  • RSS

Copyright ©2020 · The Austin Times - All Rights Reserved ·